These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 12584694

  • 1. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 2. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A.
    Oncologist; 2004 Dec; 9 Suppl 4():38-47. PubMed ID: 15459428
    [Abstract] [Full Text] [Related]

  • 3. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Dec; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 4. Emerging strategies in bone health management for the adjuvant patient.
    Coleman RE.
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S11-6. PubMed ID: 18068485
    [Abstract] [Full Text] [Related]

  • 5. Future directions in the treatment and prevention of bone metastases.
    Coleman RE.
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S32-8. PubMed ID: 12562049
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonates: clinical experience.
    Coleman RE.
    Oncologist; 2004 Dec; 9 Suppl 4():14-27. PubMed ID: 15459426
    [Abstract] [Full Text] [Related]

  • 7. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA.
    Cancer Treat Rev; 2008 Feb 01; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [Abstract] [Full Text] [Related]

  • 10. Preclinical pharmacology of zoledronic acid.
    Green JR.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):3-11. PubMed ID: 12584689
    [Abstract] [Full Text] [Related]

  • 11. The role of bisphosphonates in early breast cancer.
    Paterson AH.
    Oncologist; 2006 Dec 01; 11 Suppl 1():13-9. PubMed ID: 16971735
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates for treatment and prevention of bone metastases.
    Michaelson MD, Smith MR.
    J Clin Oncol; 2005 Nov 10; 23(32):8219-24. PubMed ID: 16278476
    [Abstract] [Full Text] [Related]

  • 13. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
    Conte P, Guarneri V.
    Oncologist; 2004 Nov 10; 9 Suppl 4():28-37. PubMed ID: 15459427
    [Abstract] [Full Text] [Related]

  • 14. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
    Can J Oncol; 1995 Dec 10; 5 Suppl 1():54-7. PubMed ID: 8853526
    [Abstract] [Full Text] [Related]

  • 15. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 10; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 16. Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
    Green JR.
    Acta Oncol; 2005 Dec 10; 44(3):282-92. PubMed ID: 16076701
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A.
    J Support Oncol; 2004 Dec 10; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G, Lipton A.
    Semin Oncol; 2010 Oct 10; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonates in breast cancer: antitumor effects.
    Aft R.
    Clin Adv Hematol Oncol; 2011 Apr 10; 9(4):292-9. PubMed ID: 21558988
    [Abstract] [Full Text] [Related]

  • 20. Optimal management of metastatic bone disease.
    Major P.
    Eur J Oncol Nurs; 2007 Apr 10; 11 Suppl 2():S32-7. PubMed ID: 17804294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.